75
Views
17
CrossRef citations to date
0
Altmetric
Perspective

Targeting host cells harbouring viruses with radiolabeled antibodies

, &
Pages 595-597 | Published online: 03 May 2007

Bibliography

  • MILENIC DE, BRADY ED, BRECHBIEL MW: Antibody-targeted radiation cancer therapy. Nat. Rev. Drug Discov. (2004) 3:488-499.
  • SHARKEY RM, GOLDENBERG DM Perspectives on cancer therapy with radiolabeled monoclonal antibodies. J. Nucl. Med. (2005) 46(Suppl. 1):115S-127S.
  • PINCUS SH, FANG H, WILKINSON RA, MARCOTTE TK, ROBINSON JE, OLSON WC: In vivo efficacy of anti-glycoprotein 41, but not anti-glycoprotein 120, immunotoxins in a mouse model of HIV infection. J. Immunol. (2003) 170:2236-2241.
  • DAVEY RT JR, BOENNING CM, HERPIN BR et al.: Use of recombinant soluble CD4 Pseudomonas exotoxin, a novel immunotoxin, for treatment of persons infected with human immunodeficiency virus. J. Infect. Dis. (1994) 170:1180-1188.
  • RAMACHANDRAN RV, KATZENSTEIN DA, WOOD R, BATTS DH, MERIGAN TC: Failure of short-term CD4-PE40 infusions to reduce virus load in human immunodeficiency virus-infected persons. J. Infect. Dis. (1994) 170:1009-1013.
  • DADACHOVA E, PATEL MC, TOUSSI S et al.: Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins. PLoS Med. (2006) 3(11):e427.
  • LEHRMAN G, HOGUE IB, PALMER S et al.: Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet (2005) 366:549-555.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.